[1]陈乔彬,刘爱胜,文 艳.深圳地区三级区属医院铜绿假单胞菌感染分布及耐药性分析[J].现代检验医学杂志,2015,30(03):147-150.[doi:10.3969/j.issn.1671-7414.2015.03.045]
　CHEN Qiao-bin,LIU Ai-sheng,WEN Yan.Infection Distribution and Drug Resistance Analysis of Pseudomonas Aeruginosa in Third District Hospital in Shenzhen Area[J].Journal of Modern Laboratory Medicine,2015,30(03):147-150.[doi:10.3969/j.issn.1671-7414.2015.03.045]
点击复制

深圳地区三级区属医院铜绿假单胞菌感染分布及耐药性分析()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第30卷
期数:
2015年03期
页码:
147-150
栏目:
检验与临床
出版日期:
2015-06-10

文章信息/Info

Title:
Infection Distribution and Drug Resistance Analysis of Pseudomonas Aeruginosa in Third District Hospital in Shenzhen Area
文章编号:
1671-7414(2015)03-147-04
作者:
陈乔彬1; 刘爱胜2; 文 艳3
1.深圳市南山区妇幼保健院检验科,广东深圳 518000;
2.深圳市龙华新区人民医院检验科,广东深圳 518109;
3.深圳市光明新区人民医院ICU,广东深圳 518106
Author(s):
CHEN Qiao-bin1; LIU Ai-sheng2; WEN Yan3
1.Department of Clinical Laboratory,Shenzhen Nanshan DistrictMaternal and Child Health Care,Guangdong Shenzhen 518000,China;
2.Department of Clinical Laboratory, Longhua New District People's Hospital of Shenzhen,Guangdong Shenzhen 518109,China;
关键词:
铜绿假单胞菌;  分离率;  分布;  耐药性
分类号:
R378.991; R446.5
DOI:
10.3969/j.issn.1671-7414.2015.03.045
文献标志码:
A
摘要:
目的 了解深圳市龙华和光明新区三家三级区属医院铜绿假单胞菌感染的临床分布特征及耐药性,为临床科学用药提供依据。方法 收集2013年6月～2014年11月三家三级区属医院各科住院临床标本共3 176份,采用梅里埃VITEK-32细菌鉴定仪进行细菌鉴定,铜绿假单胞菌阳性标本采用K-B法和微量肉汤稀释法(MIC法)进行药敏试验,并对检验结果进行统计学处理。结果 3176份标本铜绿假单胞菌总分离率为51.16%(1 625/3 176),其中痰标本为52.8%(858/1 625),其次为支气管肺泡灌洗液和脓液分别为20.1%(327/1 625)和16.7%(271/1 625)。病区主要分布在ICU、心胸外科和神经外科,分别为41.6%(676/1 625),15.9%(259/1 625)和19.1%(310/1 625)。碳青霉烯类敏感、耐碳青霉烯类和泛耐药铜绿假单胞菌分离率分别为67.1%(1 090/1 625),31.6%(514/1 625)和1.29%(21/1 625)。耐碳青霉烯类铜绿假单胞菌的耐药性较碳青霉烯类敏感的严重,除多黏菌素B外两者耐药率比较差异有统计学意义(χ2=12.617～80.654,P＜0.05～0.001),2例耐碳青霉烯类铜绿假单胞菌对多黏菌素B耐药,除阿米卡星、庆大霉素、妥布霉素有较高的敏感度外,其余11种抗菌药物的耐药率均＞60%以上。结论 临床上铜绿假单胞菌有很高的分离率,主要来源于呼吸道和ICU病区。耐碳青霉烯类铜绿假单胞菌比碳青霉烯敏感的耐药严重,应密切关注耐碳青霉烯铜绿假单胞菌耐药性发展,采取有效的预防传播与感染措施,科学使用抗菌药,杜绝耐碳青霉烯类和泛耐药铜绿假单胞菌的蔓延。
Abstract:
Objective To understand the shenzhen longhua new district and the light district three third district hospital pseudomonas aeruginosa infection the clinical distribution and drug resistance,for clinical provides the basis for scientific and medical treatment.Methods Collected 3 176 clinical specimens in three district hospital from June 2013 to November 2014 and they were done bacteria identification with VITEK-32 bacteria identification instrument of French biomerieux.For pseudomonas aeruginosa specimens using the K-B method and trace the broth dilution method(MIC)to do drug sensitive test,and the inspection results were statistically processed.Results 3 176 specimens pseudomonas aeruginosa isolated total separation rate was 51.16%(1 625/3 176),including respiratory sputum specimens was 52.8%(858/1 625),followed by bronchoalveolar lavage and pus,were 20.1%(327/1 625)and 16.7%(271/1 625).Ward,neurosurgery and thoracic surgeons are mainly distributed in the ICU,were 41.6%(676/1 625),15.9%(259/1 625)and 19.1%(310/1 625).Carbon penicillium,resistance to carbon alkene sensitive penicillium alkene and extensive drug resistance rate of pseudomonas aeruginosa isolated were 67.1%(1 090/1 625),31.6%(514/1 625)and 1.29%(21/1 625).Resistance to carbon penicillium alkene the drug resistance of pseudomonas aeruginosa from penicillium carbon alkene sensitive serious,in addition to the polymyxin B resistance to both comparative difference was statistically significant(χ2=12.617～12.617,P＜0.05～0.001),2 cases of resistance to carbon penicillium alkene pseudomonas aeruginosa to polymyxin B resistance,in addition to amikacin,gentamycin,tobramycin has high sensitivity,therest of the 11 kinds of antimicrobial drug resistance to all＞60%.Conclusion Clinical pseudomonas aeruginosa had a high separation rate,mainly comes from the respiratory tract and the distribution of the ICU ward.Penicillium carbon alkene resistant pseudomonas aeruginosa than carbon penicillium sensitive resistance was serious,should pay close attention to carbonblue mould resistant pseudomonas aeruginosa resistance development,take effective measures of preventing transmission and infection of scientific use of antimicrobials,put an end to resistance to carbon penicillium alkene and the spread of drug resistance pseudomonas aeruginosa.

参考文献/References:

[1] Clinical and Laboratory Standards Institute.Performance Standards for Antimicrobial Susceptibility testing:Twenty-First Informational Supplementr[S].Wayne:PA,CLSI M100-S21,2011.
[2] 龚鹏珠.2007～2009年ICU铜绿假单胞菌的耐药性变迁[J].中华医院感染学杂志,2012,22(1):175-176.
Gong PZ.Dynamic changes of drug resistance of Ps-eudomonas aeruginosa in ICU between 2007 and 2009[J].Chinese Journal of Nosocomiol,2012,22(1):175-176.
[3] 莫善颖,李梦薇,韦柳华,等.铜绿假单胞菌的临床分布及耐药性分析[J].中华医院感染学杂志,2013,23(22):5553-5555.
Mo SY,Li MW,Wei LH,et al.Clinical distribution and drug resistance of 609 strains of Pseudomonas aeruginosa[J].Chinese Journal of Nosocomiol,2013,23(22):5553-5555.
[4] 谭湘萍,司徒冰,刘晓玲.多重耐药铜绿假单胞菌的危险因素分析及泛耐药株的治疗初探[J].今日药学,2011,21(2):84-87.
Tan XP,Situ B,Liu XL.Analyze risk factor and treatment for multi-drug resistant Pseudomonas aeruginosa[J].Journal of Pharmacy Today,2011,21(2):84-87.
[5] 崔 巍,陈 雷.耐碳青霉烯类铜绿假单胞菌产金属β-内酰胺酶的检测及耐药性分析[J].中华医院感染学杂志,2011,21(3):560-562.
Cui W,Chen L.Detection of carbapenems-resistant Pseudomonas aeruginosa producing metallo-β-lactamase and antibiotics resistance[J].Chinese Journal of Nosocomiol,2011,21(3):560-562.
[6] 华俊彦,刘丙进,田伟强,等.340株铜绿假单胞菌感染及耐药性分析[J].医药导报,2011,30(1):109-111.
Hua JY,Liu BJ,Tian WQ,et al.Analysis for 340 cases of Pseudomonas aeruginosa infection and drug resistance[J].Herald of Medicine,2011,30(1):109-111.
[7] 张家云.铜绿假单胞菌医院感染现状及耐药性探讨[J].中华医院感染学杂志,2011,21(6):1232-1233.
Zhang JY.Investigation of Pseudomonas aeruginosa infection anddrug resistance[J].Chinese Journal of Nosocomiol,2011,21(6):1232-1233.
[8] 晏文强,刘国政,谢明水.重症监护病房医院感染铜绿假单胞菌耐药性分析[J].中华医院感染学杂志,2011,21(1):146-147.
Yan WQ,Liu GZ,Xie MS.Drug resistace of Pseudomonas aeruginosacausing nosocomial infections in ICU[J].Chinese Journal of Nosocomiol,2011,21(1):146-147.
[9] 郭小惠,张莉萍.铜绿假单胞菌耐药机制的最新研究进展[J].国际检验医学杂志,2011,32(9):968-971.
Guo XH,Zhang LP.Research progress of Pseudomonas aeruginosa resistant mechanism of thelatest[J].International Journal of Laboratory Medicine,2011,32(9):968-971.

相似文献/References:

[1]邱晓明,林锦骠,黄 尔,等.黏液型与非黏液型铜绿假单胞菌Cif基因表达研究[J].现代检验医学杂志,2016,31(03):19.[doi:10.3969/j.issn.1671-7414.2016.03.006]
　QIU Xiao-ming,LIN Jin-piao,HUANG Er,et al.Investigation of Cif Gene Expression between Mucoid and Non-mucoid Pseudonmonas Aeruginosa[J].Journal of Modern Laboratory Medicine,2016,31(03):19.[doi:10.3969/j.issn.1671-7414.2016.03.006]
[2]多丽波,李桂玲,陈淑娟,等.铜绿假单胞菌金属酶及整合酶的检测[J].现代检验医学杂志,2015,30(01):34.[doi:10.3969/j.issn.1671-7414.2015.01.010]
　DUO Li-bo,LI Gui-ling,CHEN Shu-Juan,et al.Detection of Metallo-β-Lactamases and Integrasesin from Pseudomonas Aeruginosa Isolates[J].Journal of Modern Laboratory Medicine,2015,30(03):34.[doi:10.3969/j.issn.1671-7414.2015.01.010]
[3]罗史科,刘鲜花,朱平安,等.铜绿假单胞菌对耐喹诺酮药物质粒基因的研究[J].现代检验医学杂志,2015,30(01):39.[doi:10.3969/j.issn.1671-7414.2015.01.011]
　LUO Shi-ke,LIU Xian-hua,ZHU Ping-an,et al.Research on Pseudomonas Aeruginosa Quinolone-resistant Plasmid Genes[J].Journal of Modern Laboratory Medicine,2015,30(03):39.[doi:10.3969/j.issn.1671-7414.2015.01.011]
[4]谢国艳,高志生,许 俊,等.Cica-Beta Test试剂盒检测 耐亚胺培南铜绿假单胞菌金属β-内酰胺酶的评估[J].现代检验医学杂志,2015,30(01):123.[doi:10.3969/j.issn.1671-7414.2015.01.036]
　XIE Guo-yan,GAO Zhi-sheng,XU Jun,et al.Evaluation of Cica-Beta Test Kit for Detection of Metallo-β-Lactamase-Producing Pseudomonas Aeruginosa[J].Journal of Modern Laboratory Medicine,2015,30(03):123.[doi:10.3969/j.issn.1671-7414.2015.01.036]
[5]李瑜珍,曾学辉,莫 莉,等.VITEK2 Compact全自动微生物分析仪对黏液型和非黏液型铜绿假单胞菌药敏检测评价[J].现代检验医学杂志,2016,31(04):121.[doi:10.3969/j.issn.1671-7414.2016.04.034]
　LI Yu-zhen,ZENG Xue-hui,Mo-li,et al.Evaluation of Drug Susceptibility Test to Mucoid Pseudomonas Aeruginosa and Non-Mucoid Pseudomonas Aeruginosa with VITEK2 Compact Automatic Microbiology Analyzer[J].Journal of Modern Laboratory Medicine,2016,31(03):121.[doi:10.3969/j.issn.1671-7414.2016.04.034]
[6]王 静,陈 葳,曾晓艳,等.不同标本来源铜绿假单胞菌对β-内酰胺酶耐药表型的差异性分析[J].现代检验医学杂志,2017,32(03):63.[doi:10.3969/j.issn.1671-7414.2017.03.017]
　WANG Jing,CHEN Wei,ZENG Xiao-yan,et al.Analysis of the Difference of β-Lactamase-Resistant Phenotypes by Pseudomonas Aeruginosa from Different Specimens[J].Journal of Modern Laboratory Medicine,2017,32(03):63.[doi:10.3969/j.issn.1671-7414.2017.03.017]
[7]谢国艳,肖 敏.铜绿假单胞菌D-试验阳性及阴性菌株产β-内酰胺酶的差异性分析[J].现代检验医学杂志,2018,33(03):130.[doi:10.3969/j.issn.1671-7414.2018.03.033]
　XIE Guo-yan,XIAO Min.Study on the Difference of β-Lactamases-Producing in D-Test Positive and D-Test Negative Pseudomonas Aeruginosa[J].Journal of Modern Laboratory Medicine,2018,33(03):130.[doi:10.3969/j.issn.1671-7414.2018.03.033]
[8]武爱荣,杨　乐.VITEK-2 Compact 检测奇异变形杆菌、摩根摩根菌、铜绿假单胞菌的部分药敏结果准确性评价[J].现代检验医学杂志,2020,35(06):106.[doi:doi:10.3969/j.issn.1671-7414.2020.06.026]
　WU Ai-rong,YANG Le.Accuracy Evaluation of Partial Drug Sensitivity Results of Vitek-2 CompactDetection for Proteus Singularis, Morgan Morgan and Pseudomonas Aeruginosa[J].Journal of Modern Laboratory Medicine,2020,35(03):106.[doi:doi:10.3969/j.issn.1671-7414.2020.06.026]
[9]黄秋兰,钱巧慧,范德平,等.鱼腥草联合亚胺培南对碳青霉烯耐药铜绿假单胞菌杀菌效果的体外研究[J].现代检验医学杂志,2021,36(03):118.[doi:10.3969/j.issn.1671-7414.2021.03.027]
　HUANG Qiu-lana,QIAN Qiao-hui,FAN De-pinga,et al.Vitro Study on the Bactericidal Effect of Houttuynia Cordata Combined withImipenem Against Carbapenem Resistant Pseudomonas Aeruginosa[J].Journal of Modern Laboratory Medicine,2021,36(03):118.[doi:10.3969/j.issn.1671-7414.2021.03.027]
[10]尚佳文,徐文娜,许南松,等.mCIM 和碳青霉烯酶抑制剂增强试验检测CRE 和CRPA 产酶表型的方法学评价[J].现代检验医学杂志,2023,38(03):165.[doi:10.3969/j.issn.1671-7414.2023.03.030]
　SHANG Jia-wen,XU Wen-na,XU Nan-song,et al.Methodological Evaluation of mCIM and Carbapenemase Inhibitor-enhancing Assays to Detect CRE and CRPA Enzyme Producing Phenotypes[J].Journal of Modern Laboratory Medicine,2023,38(03):165.[doi:10.3969/j.issn.1671-7414.2023.03.030]

备注/Memo

备注/Memo:
基金项目:深圳市龙华新区科技创新基金项目,项目编号:2013136。
作者简介:陈乔彬(1979-),男,本科,主管技师,从事微生物及生化免疫工作,E-mail:curious1997@163.com。
更新日期/Last Update: 2015-06-10